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Background: Liver is a target for injury in low flow states and it plays a central role in the progression of systemic
failure associated with hemorrhagic shock. Pharmacologic support can help recover liver function even after it has
suffered extensive damage during ischemia and reperfusion phases. In this work we assessed the efficacy of a
diphenyldifluoroketone EF24, an IKKβ inhibitor, in controlling hepatic inflammatory signaling caused by
hemorrhagic shock in a rat model.
Methods: Sprague Dawley rats were bled to about 50% of blood volume. The hemorrhaged rats were treated with
vehicle control or EF24 (0.4 mg/kg) after 1 h of hemorrhage without any accompanying resuscitation. The study
was terminated after additional 5 h to excise liver tissue for biochemical analyses and histology.
Results: EF24 treatment alleviated hemorrhagic shock-induced histologic injury in the liver and restored serum
transaminases to normal levels. Hemorrhagic shock induced the circulating levels of CD163 (a marker for macrophage
activation) and CINC (an IL-8 analog), as well as myeloperoxidase activity in liver tissue. These markers of inflammatory
injury were reduced by EF24 treatment. EF24 treatment also suppressed the expression of the Toll-like receptor 4,
phospho-p65/Rel A, and cyclooxygenase-2 in liver tissues, indicating that it suppressed inflammatory pathway.
Moreover, it reduced the hemorrhagic shock-induced increase in the expression of high mobility group box-1
protein. The evidence for apoptosis after hemorrhagic shock was inconclusive.
Conclusion: Even in the absence of volume support, EF24 treatment suppresses pro-inflammatory signaling in
liver tissue and improves liver functional markers in hemorrhagic shock.
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The morbidity and mortality associated with hemorrhagic
shock (HS) is a composite result of systemic inflammatory
response syndrome (SIRS) caused by hemorrhage and
reperfusion. Liver is one of the vital organs in this coor-
dinated bodily response to HS and approximately 20%
of HS victims exhibit some degree of liver dysfunction
[1,2]. Given the role played by liver in metabolic, excre-
tory, and homeostatic mechanisms, liver injury is directly
linked to the systemic deterioration which may nullify the
effectiveness of resuscitation strategies in shock. At the
same time, liver is sufficiently resilient to recover even
after it has suffered extensive damage, suggesting that* Correspondence: vibhudutta-awasthi@ouhsc.edu
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unless otherwise stated.effective pharmacologic strategies early in shock may help
liver tissue survive ischemic and reperfusion injury. Several
pharmacologic substances such as 2-mercaptopropionyl
glycine [3], melatonin [4], and ethyl pyruvate [5] are being
investigated in preclinical models to maintain liver func-
tion after HS and reperfusion injury. It is notable that in a
multifaceted pathology of shock, mono-therapies, such as
infliximab against tumor necrosis factor-alpha (TNF-α) or
Xigris™ targeting activated protein C, fail to provide
expected clinical outcomes. Therefore, compounds with
pleiotropic effects via modulation of transcriptional factors
may be more effective because of their influence on
multiple pathways involved in SIRS pathogenesis. The
molecular pathways influenced by transcription factor
nuclear factor kB (NF-kB) play the most important role
in orchestrating the inflammatory response through the
cytokines and the transcriptional control.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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induction of inducible nitric oxide synthase (iNOS) and
cyclooxygenase-2 (COX-2) genes, is believed to contrib-
ute to the liver injury in shock [6]. Although iNOS and
COX-2 pathways can also be controlled by transcription
elements hypoxia-inducing factor-1, activator protein-1,
and p53 [7], NF-κB is the most ubiquitous rapid response
transcription factor involved in these inflammatory reac-
tions. Among several pathways leading up to the activa-
tion of NF-kB, the ligand binding to pro-inflammatory
receptors of interleukin (IL)-1 receptor superfamily is the
most important pathway. One member of the IL-1 recep-
tor family is the toll-like receptor 4 (TLR4). The TLR4
serves as a binding partner to lipopolysaccharide (LPS) as
well as to the molecules categorized as damage-associated
molecular pattern (DAMP). High mobility group box-1
(HMGB1) is one such DAMP protein which is released
from necrotic cells and binds to the TLR4 to activate
TLR4/NF-kB axis [8].
The objective of this study was to evaluate the effects
of a novel NF-kB inhibitor, EF24, on the inflammatory
injury of liver in a rat model of HS. Chemically, EF24 is a
chalcone compound, 3,5-bis(2-fluorobenzylidene)piperi-
din-4-one, which was synthesized as a curcumin analog
for its more potent anti-proliferative activity than cur-
cumin [9]. In this respect, EF24 has been investigated as
an anti-cancer agent in both in vitro and in vivo models
of cancer [10-12]. It has also been shown to potently
suppress NF-kB activation, modulate phenotype, and re-
duces secretion of TNF-α and IL-6 in lipopolysaccharide-
stimulated dendritic cell model of sterile inflammation
[13]. The putative mechanism of its activity is based on its
ability to inhibit the catalytic activity of IkappaB kinase β
(IKKβ) [14]. IKKβ phosphorylates the inhibitor of NF-kBα
(IkBα) and destines it towards proteolytic degradation.
The degradation of IkBα liberates NF-kB for phosphoryl-
ation-dependent nuclear translocation and transcriptional
activity. We have recently shown that EF24 treatment in
a rat model of 50% HS reduces pulmonary inflamma-
tion, restores intestinal barrier function, and improves
overall survival rate [15-17]. Here, we hypothesized that
EF24 administration will reduce the activation of pro-
inflammatory TLR4/NF-kB/COX-2 pathway and improve
markers of liver function.
Methods
EF24 was synthesized in-house by the procedure pub-
lished elsewhere [12]. For all the experiments, a sterile
solution of EF24 was prepared in water having endotoxin
content less than 0.1 EU/ml (Caisson Laboratories, North
Logan, UT). The primary rabbit antibodies against rat
antigens were obtained from Cell Signaling Technology
(CST, Danvers, MA) and Santa Cruz Biotechnology (SCBT,
Santa Cruz, CA). Horseradish peroxidase (HRP)-conjugatedsecondary antibodies were from Sigma-Aldrich (St. Louis,
MO). All other chemicals were obtained from various
vendors represented by VWR International (Radnor, PA).
Rat model of fixed-volume hemorrhage
The animal experiments were performed according to the
NIH Animal Use and Care Guidelines and were approved
by the Institutional Animal Care and Use Committee of
the University of Oklahoma Health Sciences Center. Male
Sprague Dawley rats (250-300 g) were obtained from the
breeding colony of Harlan Laboratories (Indianapolis, IN,
USA). The rats were housed in regular light/dark cycles of
12/12. Before initiating the experiment, the rats were
allowed to acclimatize for at least 5 days. An arterial cath-
eter was implanted in the left femoral artery in an aseptic
manner. The catheter was subcutaneously tunneled and
secured to the nape. The rats were under isoflurane (3%)
anesthesia in 100% oxygen stream (2 L per min) during
the surgical procedure. The detailed method for femoral
artery cannulation is described elsewhere [18]. The rats
were allowed 2 days to recover from the cannulation sur-
gery before their recruitment in the experiments. The can-
nulated rats were clustered in three groups: control (Ctrl,
n = 6), HS only (HS, n = 6), and HS treated with EF24
(HS→ EF24, n = 6). On the day of the experiment, the rats
were handled under isoflurane (3%) anesthesia in a stream
of medical grade air containing 21% oxygen (2 L per min).
No attempt was made to regulate the core body
temperature and the rats were allowed to freely access
water and food. For uninterrupted blood withdrawal,
the rats were heparinized with 100 units of heparin
and HS was induced by withdrawing approximately
50% of circulating blood at the rate of 1.0 ml/min. The
blood withdrawal was stopped when the desired volume
of blood loss was reached, and the rats were allowed to
wake up. The total volume of blood was estimated as 6%
of bodyweight. After allowing the hypovolemic rats to
freely compensate for 1 h, 0.4 mg/Kg bodyweight of EF24
in 100 μl isotonic volume was administered intraperitone-
ally. The rats in HS group received equal volume of
vehicle in which EF24 was dissolved. The mean arterial
blood pressure (MAP) and hematocrit were monitored at
baseline, after hemorrhage, and before euthanasia as de-
scribed previously [16]. The rats were euthanized after 5 h
of EF24 administration to harvest liver tissue. The blood
samples were collected upon termination of the study;
plasma was separated for various assays.
Growth-regulated gene product/cytokine-induced
neutrophil chemoattractant (GRO/CINC-1) assay
GRO/CINC-1 is a rat analog of IL-8, which is produced
by injured tissues and serves as a chemoattractant for
neutrophils. We estimated GRO/CINC-1 in rat plasma
collected at 6 h by using an immunoassay kit (Enzo Life
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instructions provided with the kit.
Myeloperoxidase (MPO) assay
The liver tissue-associated MPO activity is an indicator
of neutrophil infiltration in inflammation. We performed
assay in Ctrl, HS, and HS→ EF24 groups. We used a
colorimetric assay using O-dianisidine dihydrochloride
as a peroxidase probe [17].
Immunohistochemistry (IHC) and histopathology
We determined the expression levels of the TLR4,
phospho-NF-κB p65, and COX-2 to assess the activation
of pro-inflammatory pathway. The presence of these
proteins in liver tissues was assessed by using an IHC kit
from DakoCytomation (Carpinteria, CA). The sectioning
and slide preparation of paraformaldehyde-fixed and
paraffin-embedded tissues was performed by the core
imaging facility of the Oklahoma Medical Research
Foundation (OMRF, Oklahoma City, OK). For staining,
the slides were blocked with a protein-block solution
and incubated overnight with phospho-NF-κB-p65
(CST), COX-2 (SCBT), and the TLR4 (CST) antibodies
at the dilutions of 1:200, 1:100, and 1:200, respectively.
After functionalization with biotinylated link universal
antiserum and a reaction with HRP-streptavidin conju-
gate, the color was developed using 3,3-diaminobenzi-
dine hydrochloride. The sections were counterstained
with Mayer’s hematoxylin solution. Digital brightfield
images of immunostained slides were captured using
Olympus IX-701 inverted microscope with an X40
objective lens and a DP70 camera (Olympus; Melville,
NY). Three animals per treatment group were analyzed
for each biomarker. Manual selection technique was
used to classify the areas positively stained with DAB
chromogen and counted directly on the screen [19,20].
For histopathologic examination, the paraffin-embedded
tissues were stained with hematoxylin and eosin. The
slides were examined by a board-certified veterinary path-
ologist for the assessment of liver injury, inflammation,
and ischemic coagulative necrosis.
Immunoblotting
The expression of the TLR4, phospho-NF-κB-p65, and
COX-2 was also examined by immunoblotting. Since the
transcriptional activity of NF-κB is regulated by phos-
phorylation of p65 subunit at Ser536 [21], the tissue
expression of phospho-p65 subunit was taken as an
indicator of NF-kB activation. The liver tissue homoge-
nates were prepared in ice-cold buffer consisting of
10% Nonidet P-40, 5 M NaCl, 1 M HEPES, 0.1 M ethylene
glycol tetraacetic acid, 0.5 M ethylenediaminetetraacetic
acid, 1 M NaF, 0.2 M sodium orthovanadate, 0.1 M phenyl-
methylsulfonyl fluoride, 2 mg/ml aprotinin, and 2 mg/mlleupeptin. The proteins were fractionated by SDS-
polyacrylamide gel electrophoresis, electrotransferred
to the nitrocellulose membranes, blotted with primary
antibodies against phospho-NF-κB-p65 (CST), the
TLR4 (CST), HMGB1 (CST), and COX-2 (SCBT),
followed by HRP-conjugated secondary antibody. The
immunoreactive bands were detected by SuperSignal
West Femto detection reagent (Thermo Fisher Scientific,
Rockford, IL). To ensure equal protein loading, the mem-
branes were stripped using a stripping solution containing
10% SDS and 0.5 M Tris and β-mercaptoethanol at 60°C
for 45 minutes, and reprobed with anti-actin antibody
(Sigma-Aldrich, St. Louis, MO). The membrane blocking
reagents and the antibody dilutions were prepared accord-
ing to the manufacturer’s recommendations.
Systemic markers of liver injury
The plasma levels of aspartate transaminase (AST) and
alanine transaminase (ALT) are clinical markers of
hepatic injury. Likewise, the plasma levels of CD163
are indicative of the activation status of liver Kupffer
cells [22,23]. The plasma levels of the AST and ALT
were measured by using a kit from Biovision (Milpitas,
CA). The plasma concentration of rat CD163 (also
known as scavenger receptor cysteine-rich type 1 pro-
tein M130) was estimated by using an enzyme-linked
immunoassay (ELISA) kit from MyBioSource (San Diego,
CA).
Apoptosis
The induction of apoptosis in liver was studied by im-
munoblotting (described above) for caspase-3, caspase-
9, caspase-8, BAX, Bcl-2, and survivin. Caspase-9,
caspase-8, caspase-3, and BAX are the pro-apoptotic
proteins, whereas Bcl-2 and survivin are regarded as
the anti-apoptotic proteins. The primary antibodies
were acquired from CST. The fragmented DNA of
apoptotic cells in liver tissue slices were end-labeled
using a modified terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) assay supplied as a
fluorometric kit (Promega, Madison, WI). The section-
ing and staining of the tissues was performed in the
OMRF’s core imaging facility (Oklahoma City, OK).
Data analysis
The results were analyzed by analysis of variance
(ANOVA) and the Bonferroni post-test using Prism
software (GraphPad Software, Inc., San Diego, CA).
The p value < 0.05 was considered statistically signifi-
cant. The densitometry of immunoreactive bands was
performed on at least three replicates for each experi-
ment using ImageJ 1.46r freeware (National Institutes
of Health).
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We describe the effects of EF24 administration on hepatic
TLR4/NF-kB/COX-2 pathway of inflammation, markers
of liver injury (tissue MPO and HMGB1 expression;
plasma AST and ALT), apoptosis (caspases, BAX, Bcl-2,
and survivin), and the plasma levels of CD163 as an in-
dicator of macrophage activation in rats with 50% HS.
After blood loss, the mean arterial blood pressure in
this model dropped from 97.5 ± 6.9 mm Hg at baseline
(hematocrit = 44.1 ± 1.3) to 43 ± 4.1 mm Hg after
hemorrhage (hematocrit = 27.4 ± 1.1).
EF24 ameliorates HS-induced liver injury
The acute histopathologic consequences of HS in liver
are shown in Figure 1A. At necropsy, the effect of blood
loss was blanching of the liver lobes which remained so
even after EF24 treatment, but no apparent areas of
macroscopic necrosis were observed. There was also no
histologic evidence of ischemic necrosis that would have
first developed within the centrilobular zones. Under the
microscope, the control liver slices revealed normal
architecture, with a preserved trabecular structure of
parenchyma cells. In rats suffering from HS, the hepato-
cellular architecture was deranged, characterized by mild
to moderate cytoplasmic swelling with partial loss of the
sinusoidal spaces in hemorrhaged rats. These changes
were substantially reduced in liver of rats treated with
EF24 (0.4 mg/Kg).
Treatment with EF24 markedly ameliorated the
HS-induced increase in MPO activity, as well as theFigure 1 Effects of hemorrhagic shock and EF24 treatment on liver. (A
showing EF24-assisted recovery from hemorrhage-induced damages. The tiss
were obtained at 100X magnification. (B) Myeloperoxidase (MPO) activity in li
levels in plasma collected at 6 h after HS. (E) Plasma levels of CD163 (n = 5/grplasma levels of AST, ALT and CD163 (Figure 1B-E).
As shown in Figure 1B, HS increased the tissue-associated
MPO activity by 3-folds (Ctrl 0.09 ± 0.005 vs. HS 0.27 ±
0.043, p < 0.05) and treatment with EF24 reduced it to
0.08 ± 0.007 (p < 0.05, HS→EF24 vs. HS). Similarly, HS
increased the plasma AST and ALT levels by approxi-
mately 40% and 66% over control levels, respectively
(Ctrl vs. HS, p < 0.05), which were normalized to nor-
mal levels by EF24 treatment (p < 0.05, HS→EF24 vs.
HS) (Figure 1C and D). The HS-induced increase in
CD163 concentration in plasma was more than 8-folds,
from control levels of 8.1 ± 1.4 to 68.9 ± 1.6 μg/ml in HS
(Ctrl vs. HS, p < 0.05) (Figure 1E). EF24 treatment re-
duced the soluble CD163 in plasma to 39.8 ± 7.0 μg/ml
(p <0.05, HS→EF24 vs. HS), but these circulating levels
were significantly above the control levels (p < 0.05,
HS→EF24 vs. Ctrl).
Figure 2 shows that HS induced the expression of
BAX and mild cleavage of caspase-8 and caspase-3, but
there was no cleavage of caspase-9. Simultaneously,
there was a reduction in the expression of Bcl-2 and
survivin. When the hemorrhaged rats were treated
with EF24, the expression levels of these proteins
tended to shift back to their basal levels, suggesting
that EF24 treatment blocked the weak induction of ex-
trinsic apoptotic pathway. None of the changes in HS
and EF24-treated groups satisfied the statistical signifi-
cance of p < 0.05. The absence of marked induction of
apoptosis was also supported by the lack of clear evi-
dence in fluorescence microscopy of TUNEL-stained1-A3) Histopathology of liver tissues from a representative set of rats,
ue slides were stained with hematoxylin & eosin and digital micrographs
ver tissues (n = 5/group). (C) AST (n = 6/group) and (D) ALT (n = 6/group)
oup) at 6 h after HS. * p < 0.05 vs. Ctrl and # p < 0.05 vs. HS.
Figure 2 Effects of hemorrhagic shock and EF24 treatment on apoptotic markers. (A) Expression of caspase-3, caspase-9, caspase-8,
Bcl-2, Bax, and survivin in liver tissues (n = 3/group). (B) The membranes were stripped and re-probed with anti-β-actin antibody
to determine the actin-normalized densitometry units. Sham surgery (Ctrl), hemorrhage (HS) and hemorrhage with EF24 administration
(HS→ EF24).
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from various groups of rats was not different (data not
shown).
EF24 suppresses HS-induced CINC-1 expression in liver
Figure 3A shows that HS caused a significant increase
in liver tissue-associated CINC-1 from 0.08 ± 0.006 to
0.44 ± 0.044 pg/ml (Ctrl vs. HS, p < 0.05). EF24 treat-
ment significantly lowered the HS-induced hepatic
CINC-1 levels to 0.075 pg/ml (p < 0.05, HS→EF24 vs.
HS). In addition, by immunoblotting we found that HS
induced the expression of HMGB1 by approximately
5-folds (Ctrl vs. HS, p < 0.05), which was substantially
reduced by EF24 treatment (Figure 3B). Interestingly,
the mobility of HMGB1 band in hemorrhaged liver was
conspicuously slowed as compared to that observed in
case of tissues from control and EF24-treated rats.EF24 inhibits HS-induced TLR4 expression, NF-κB activation,
and COX-2 expression
The IHC staining of liver slices demonstrated that HS
significantly increased the expression levels of the
TLR4 (Figure 4A and B). The TLR4 positive cells in-
creased from 109 ± 1.8 (mean ± sem) in control groups
to 206 ± 7.5 in HS group (p < 0.05). EF24 treatment
reduced the TLR4 positivity to 147 ± 6.4 (p < 0.05, vs.
HS). The immunoblots for the TLR4 expression and
the actin-normalized densitometry of blots also pro-
vided evidence of changes in the TLR4 expression after
HS and EF24 treatment (Figure 4C and D). The expres-
sion of the TLR4 was increased in HS group by about 1.6
times and EF24 treatment brought it down to approxi-
mately 1.26 times as compared to the control levels.
Whereas the HS-induced change in the TLR4 expression
was significant (p <0.05, vs. Ctrl), the reduction caused by
Figure 3 EF24 treatment reduces hemorrhage-induced CINC-1
and HMGB1 expression. (A) CINC expression in liver tissue
estimated by ELISA (n = 4/group). (B) HMGB1 expression in liver
tissue of hemorrhaged rats treated with EF24 (n = 4/group). The
protein expression of HMGB1 was observed by immunoblotting
(Upper panel), and the actin-normalized densitometry units were
calculated (Lower panel). * p < 0.05 vs. Ctrl and # p < 0.05 vs. HS.
Yadav et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine  (2015) 23:8 Page 6 of 11EF24 treatment was not statistically significant with
respect to densitometry.
The IHC examination also revealed a clear induction
of the phospho-NF-κB p65 expression in liver tissue
after HS. The treatment with EF24 prevented this induc-
tion in a significant manner (Figure 5A and B). The stain
positivity for the phospho-NF-κB p65 expression in Ctrl,
HS, and HS→EF24 groups was 164 ± 11.9, 251 ± 6.5, and
150 ± 10.9, respectively (p <0.05, Ctrl vs. HS and HS vs.
HS→EF24). Furthermore, the immunoblotting of liver
tissue homogenates for the phospho-NF-κB p65 ex-
pression confirmed that HS induced the expression of
phospho-NF-κB p65 and EF24 treatment reduced thisinduction (Figure 5C and D). The densitometry-based
analyses revealed that compared to the control group,
the expression of phospho-NF-κB p65 increased by
approximately 3 times in HS group (p < 0.05, vs. Ctrl),
whereas EF24 treatment reduced the expression to
approximately 1.5 times (p < 0.05, vs. HS).
Like the TLR4 and the phospho-NF-κB p65 expres-
sion, the IHC (Figure 6A and B) and immunoblotting
(Figure 6C and D) evidence for COX-2 expression also
showed that EF24 treatment inhibited the HS-induced
COX-2 expression in liver tissue. The number of COX-2
positive cells increased from control levels of 132 ± 11.6 to
297 ± 6.9 in HS group (p < 0.05, vs. Ctrl). The number of
COX-2 positive cells reduced to approximately 201 ± 3.7
in EF24-treated rat liver (p < 0.05, vs. HS). Based on
the densitometry of immunoblots, in comparison to
the control level, the expression levels of COX-2 in HS
and HS→EF24 groups was 2.09 ± 0.24 and 1.68 ± 0.29,
respectively (p <0.05, Ctrl vs. HS and p = 0.098, HS vs.
HS→EF24).
Discussion
We previously reported the salutary effects of EF24 on
lungs of rats with HS [15,16]. EF24 treatment increased
the 6 h survival in this model from 36% in the untreated
group to 75% in the treated group of rats [16]. The liver
is another organ of immense importance in HS. HS not
only diminishes volume-flow through the hepatic artery
and portal vein, but also reduces oxygen saturation of
the venous blood from 15% to ≤ 5% in the portal vein
which accounts for approximately 75% of blood supply
to the liver [24]. The resultant hypoperfusion and
hypoxia often results in irreversible hepatic injury if
the low flow state is allowed to persist for long, or the
hemodynamics-preserving resuscitation is delayed [25].
Liver failure in shock is a part of the multiple organ
dysfunction syndrome, the principal driver of which is
the excessive activation of inflammatory pathways in
the affected organs [26,27]. It has been suggested that
modulation of inflammatory process by inhibiting the
TLR4/NF-kB axis could be exploited for mitigation of
the organ damage caused by HS [28,29]. In this regard,
EF24 has been shown to inhibit NF-kB activation by
interfering with the catalytic activity of IkappaB kinase β
(IKKβ) [14]. Chemically, EF24 belongs to the chalcone
group of compounds. Chalcones are mostly researched for
their anti-cancer activity [30-32], but none has been in-
vestigated for the mitigation of SIRS in shock. Herein,
we describe the salutary effects of EF24 administration
on HS-associated liver damage.
NF-kB is an important pivot in signaling of the IL-1R
superfamily which includes the TLR4. The TLR4-ligand
interaction could activate the NF-κB-dependent as well as
NF-κB-independent inflammatory pathways. Although the
Figure 4 EF24 reduces hemorrhage-induced expression of TLR4. (A) Immunohistochemical analysis of TLR4 expression in liver tissues of rats
subjected to sham surgery (Ctrl), hemorrhage (HS) and hemorrhage with EF24 administration (HS→ EF24). The light blue stain represents the
degree of expression of TLR4. (B) Quantitation of IHC values (* p < 0.05 vs. Ctrl and # p < 0.05 vs. HS; n = 3/group). (C) Immunoblots showing the
TLR4 protein expression in three different sets. To demonstrate equal loading, the membranes were stripped and re-probed with anti-β-actin
antibody. (D) Actin-normalized densitometry of TLR4 immunoblots.
Yadav et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine  (2015) 23:8 Page 7 of 11TLR4 is placed upstream of NF-kB pathway, our results
indicate that EF24 also reduces the expression of the
TLR4. This could be because of the transcriptional control
exercised by NF-kB over the TLR4 expression. NF-κB
recruits E2F1 as a transcription partner to activate its
genome-wide LPS-responsive genes including the TLR4
[33]. NF-κB also transcriptionally controls the COX-2
gene that is inducible by HS and reperfusion injury.
The eicosanoids generated from COX-2 activation are
important players in the manifestation of inflammatory
pathology. We found that EF24 treatment subdued the
induction of COX-2 protein in hemorrhaged liver tissue.
In addition to the eicosanoids generated from COX-2 in-
duction, the effector soluble factors in the NF-kB pathway
also include the cytokines, such as TNF-α and IL-6; a
strong correlation between the serum cytokines levels and
the therapeutic outcome exists in victims of shock [34].
EF24 was found to significantly suppress the expression of
CINC-1 in liver tissue (Figure 3). CINC-1 is a powerful
neutrophil chemoattractant expressed by macrophages in
the inflamed tissue. A direct link also exist between the
suppression of pro-inflammatory TLR4/NF-kB axis by
EF24 treatment and the reduced CD163 expression and
shedding. Shedding of CD163 into the circulation has
been shown to occur after the TLR activation [35]. Theexpression of CD163 antigen in the macrophages itself
has been shown to be controlled by various NF-kB-
regulated inflammatory mediators such as interferon γ
and IL-6, and it is thought that CD163-expressing cells
have a role in regulation of the immune response [36,37].
Furthermore, COX-generated prostaglandin E2 has been
reported to play a direct role in regulating the expression
of CD163 on monocytes in human liver tissues [38]. Thus,
it could be hypothesized that the reduced levels of plasma
CD163 in EF24-treated rats is a result of the suppression
of inflammatory signaling in the ischemic and hypo-
perfused liver.
Cell death in the liver occurs mainly by apoptosis or
necrosis, with participation of other variants (necrop-
tosis, autophagy, and pyroptosis) depending upon the
nature and duration of insult [39]. The biochemical
evidence for apoptotic cell death in our model of HS
was not convincing (Figure 2) because there was no in-
duction of caspase-9, weak activation of caspase-8 and
caspase-3, and negative TUNEL staining in the liver
tissue. The only sure signs related to apoptosis were
the HS-induced decreased expression of anti-apoptotic
Bcl-2 and increased expression of pro-apoptotic Bax
protein. However, Bcl-2 and Bax expression levels are
not the conclusive proofs of apoptosis because they
Figure 5 EF24 reduces hemorrhage-induced expression of phospho-NF-κB p65. (A) Immunohistochemical analysis of phospho-NF-kB p65
expression in liver tissues of rats subjected to sham surgery (Ctrl), hemorrhage (HS) and hemorrhage with EF24 administration (HS→ EF24). The light
blue stain represents the degree of expression of phospho-p65. (B) Quantitation of IHC values (* p < 0.05 vs. Ctrl and # p < 0.05 vs. HS; n = 3/group).
(C) Immunoblots showing the phospho-NF-kB p65 expression in three different sets. To demonstrate equal loading, the membranes were stripped
and re-probed with anti-β-actin antibody. (D) Actin-normalized densitometry of the immunoblots.
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of apoptotic signatures in our model is different from
the observations made in several other investigations,
perhaps because the other studies administered resus-
citation fluids in their study models [42-44]. In con-
trast, we employed a model of prolonged ischemia
without any fluid resuscitation. It has been postulated
that apoptotic cell death occurs mainly during the res-
toration of the circulation and oxygen supply, whereas
ischemia associated with massive blood loss causes
hepatocytes to undergo necrosis [45]. Presumably, the
energy needs associated with the apoptosis process
restrict it to occur only during the reperfusion phase
because it depends on oxidative metabolism in the
cells [46]. Elsewhere, Paxian et al have reported that
prolonged period of hemorrhagic hypotension was
associated with necrosis whereas resuscitation within a
short duration of shock induced apoptosis in hepatic
tissue [47]. Therefore, we speculate that liver cells
undergo type III or necrotic cell death after prolonged
HS. However, the light microscopic pathology could
not adequately define necrosis in our rat model. The
mild hepatic injury observed in our rat model may be
because of the short duration (6 h) of shock which per-
haps is not sufficiently long for large scale histologic and
functional changes to become evident.The usual criteria employed to establish necrotic cell
death are the absence of apoptosis and the release of
intracellular proteins such as HMGB1 and cytokeratin
18 [48]. HMGB1 is a chromatin structural protein
which is released in the extracellular milieu from
trauma-afflicted necrotic cells, but remains bound to
DNA in apoptotic cells. Upon extracellular release,
HMGB1 acts like a DAMP and activates inflammatory
pathways by interacting with the TLR4 and other pro-
inflammatory receptors [8]. Given that EF24 treatment
suppressed the expression of HMGB1 in the liver tissue of
hemorrhaged rats, it appears that EF24 reduced the induc-
tion of necrotic cell death. Another interesting observa-
tion was the conspicuous mobility shift of the HMGB1
band in the immunoblots (Figure 4). We speculate that
this mobility-shift is because of its altered state of acetyl-
ation. Since acetylation neutralizes the positive charge of
the ε-amino group of lysine, there is an increase of the net
negative charge of the SDS-protein complexes, without
significantly changing the molecular mass of the protein
[49]. Translocation of HMGB1 from nucleus to cytosol is
favored by its hyperacetylation [50]. It has also been
shown that the suppression of histone deacetylase activity
in the nucleus contributes to the increase in acetylated
HMGB1 release after oxidative stress in ischemic hepato-
cytes [51].
Figure 6 EF24 reduces hemorrhage-induced expression of COX-2. (A) Immunohistochemical analysis of COX-2 expression in liver tissues of
rats subjected to sham surgery (Ctrl), hemorrhage (HS) and hemorrhage with EF24 administration (HS→ EF24). The light blue stain represents the
degree of expression of COX-2. (B) Quantitation of IHC values (* p < 0.05 vs. Ctrl and # p < 0.05 vs. HS; n = 3/group). (C) Immunoblots showing
COX-2 expression in three different sets. To demonstrate equal loading, the membranes were stripped and re-probed with anti-β-actin antibody.
(D) Actin-normalized densitometry of COX-2 immunoblots.
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are reliable markers of hepatocellular injury and even
mildly elevated levels of these enzymes are considered a
sign of serious underlying condition. Likewise, plasma
levels of CD163 are indicative of the activation status of
the liver Kupffer cells [22,23]. The effect of EF24 treat-
ment on the plasma AST and ALT levels in hemorrhaged
rats suggested an improvement in the functional status
of hepatic parenchyma. However, we speculate that the
primary effect of EF24 is on the neighboring Kupffer
cells because EF24 treatment significantly reduced the
circulating levels of CD163 in HS (Figure 1E). CD163 is a
macrophage lineage-specific endocytic scavenger receptor
for haptoglobin-hemoglobin complexes which is a marker
for activated macrophages [22,52]. The soluble form of
CD163 (sCD163) has been shown to increase in plasma
after liver injury [23]. Since Kupffer cells constitute the
large majority of body macrophages, they are regarded as
the primary source of sCD163 in circulation [22]. Sec-
ondly, the cytokines, eicosanoids, oxygen free radicals and
enzymes released by activated Kupffer cells influence the
metabolic activity of the liver parenchymal cells [53]. A
paracrine circuit between the activated Kupffer cells and
hepatocytes is an early event in the induction of post-
ischemic oxidative stress in the liver [54].Conclusions
In summary, we demonstrate for the first time that an
NF-kB inhibitor EF24 has a potent salutary effect on
liver of severely hemorrhaged rats. By inhibiting the
pro-inflammatory TLR4/NF-kB/COX-2 pathway signaling,
EF24 improved the classical serum biomarkers of hepatic
injury. The encouraging results of this study warrant fur-
ther trials involving EF24 in combination with crystalloids
or whole blood resuscitation in a reperfusion model.
Furthermore, it will be of interest to investigate the tar-
get cell-type for EF24 activity. Based on our previous
work in lipopolysaccharide-stimulated dendritic cells and
EF24 [13], we hypothesize that the anti-inflammatory ef-
fect of EF24 is primarily on the resident macrophages and
its salutary effect on hepatocytic function may be second-
ary. This hypothesis is also supported by our observations
about the circulating levels of CD163 as described above.
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